Personalized neoantigen DNA vaccine GNOS-PV02 and pembrolizumab as second-line treatment for advanced hepatocellular carcinoma

被引：0
|
作者：
Yarchoan, Mark
Gane, Edward J.
Marron, Thomas U.
Perales-Linares, Renzo
Yan, Jian
Cooch, Neil
Shu, Daniel
Fertig, Elana J.
Kagohara, Luciane T.
Bartha, Gabor
Northcott, Josette
Lyle, John
Rochestie, Sarah
Peters, Joann
Connor, Jason
Jaffee, Elizabeth
Perales-Puchalt, Alfredo
Weiner, David B.
Csiki, Ildiko
Sardesai, Niranjan Y.
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-1191
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1191
引用
收藏
页数：2
相关论文
共 50 条
  • [1] PERSONALIZED DNA NEOANTIGEN VACCINE (GNOS-PV02) IN COMBINATION WITH PLASMID IL-12 AND PEMBROLIZUMAB FOR THE TREATMENT OF PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA
    Yarchoan, Mark
    Gane, Edward
    Marron, Thomas
    Rochestie, Sarah
    Cooch, Neil
    Peters, Joann
    Csiki, Ildiko
    Perales-Puchalt, Alfredo
    Sardesai, Niranjan
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A481 - A481
  • [2] Personalized Neoantigen DNA Vaccine (GNOS-PV02) and Pembrolizumab Develop Antitumor Poly-Functional Neoantigen-Specific CD4+and CD8+Effector T Cells in Advanced Hepatocellular Carcinoma Therapy
    Perales, Renzo
    Yan, Jian
    Yarchoan, Mark
    Gane, Edward
    Marron, Thomas
    Cooch, Neil
    Shu, Daniel
    Fertig, Elana
    Kagohara, Luciane
    Bartha, Gabor
    Northcott, Josette
    Lyle, John
    Rochestie, Sarah
    Peters, Joann
    Connor, Jason
    Jaffee, Elizabeth
    Perales-Puchalt, Alfredo
    Weiner, David B.
    Csiki, Ildiko
    Sardesai, Niranjan Y.
    MOLECULAR THERAPY, 2024, 32 (04) : 3 - 4
  • [3] PERSONALIZED DNA NEOANTIGEN VACCINE (GNOSPV02) IN COMBINATION WITH PLASMID IL-12 AND PEMBROLIZUMAB AS SECOND-LINE (2L) TREATMENT FOR ADVANCED HEPATOCELLULAR CARCINOMA (HCC)
    Gane, Edward
    Yarchoan, Mark
    Marron, Thomas
    Rochestie, Sarah
    Perales, Renzo
    Cooch, Neil
    Yan, Jian
    Peters, Joann
    Weiner, David
    Csiki, Ildiko
    Perales-Puchalt, Alfredo
    Sardesai, Niranjan
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A724 - A724
  • [4] IMMUNE PRESSURE IN AN ADVANCED HEPATOCELLULAR CANCER PATIENT FOLLOWING TREATMENT WITH PERSONALIZED NEOANTIGEN DNA VACCINE (GNOS-PV02) IN COMBINATION WITH PLASMID IL-12 (PIL12) AND ANTI-PD1 (PEMBROLIZUMAB)
    Yarchoan, Mark
    Gane, Edward
    Perales, Renzo
    Perales-Puchalt, Alfredo
    Bartha, Gabor
    Rochestie, Sarah
    Cooch, Neil
    Peters, Joann
    Csiki, Ildiko
    Yan, Jian
    Sardesai, Niranjan
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A722 - A722
  • [5] Effect of personalized immunization with GNOS-PV02 of patients with hepatocellular carcinoma on TCR clonal expansion, tumor infiltration, and vaccine-specific reactivity
    Perales, Renzo
    Cooch, Neil
    Yarchoan, Mark
    Sardesai, Niranjan Y.
    Yan, Jian
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [6] CIRCULATING TUMOR DNA ANALYSIS OF ADVANCED HEPATOCELLULAR CANCER (HCC) PATIENTS TREATED WITH NEOANTIGEN TARGETED PERSONALIZED CANCER DNA VACCINE (GNOS-PV02) IN COMBINATION WITH PLASMID IL-12 (PIL12) AND ANTI-PD1 (PEMBROLIZUMAB)
    Perales, Renzo
    Perales-Puchalt, Alfredo
    Bartha, Gabor
    Northcott, Josette
    Chen, Richard
    Lyle, John
    Norton, Dan
    Cooch, Neil
    Gane, Edward
    Yarchoan, Mark
    Marron, Thomas
    Rochestie, Sarah
    Peters, Joann
    Csiki, Ildiko
    Yan, Jian
    Sardesai, Niranjan
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A723 - A723
  • [7] Personalized neoantigen vaccine and pembrolizumab in advanced hepatocellular carcinoma: a phase 1/2 trial
    Yarchoan, Mark
    Gane, Edward J.
    Marron, Thomas U.
    Perales-Linares, Renzo
    Yan, Jian
    Cooch, Neil
    Shu, Daniel H.
    Fertig, Elana J.
    Kagohara, Luciane T.
    Bartha, Gabor
    Northcott, Josette
    Lyle, John
    Rochestie, Sarah
    Peters, Joann
    Connor, Jason T.
    Jaffee, Elizabeth M.
    Csiki, Ildiko
    Weiner, David B.
    Perales-Puchalt, Alfredo
    Sardesai, Niranjan Y.
    NATURE MEDICINE, 2024, 30 (03) : 1044 - 1053
  • [8] Personalized DNA neoantigen vaccine in combination with plasmid IL-12 and pembrolizumab for the treatment of patients with advanced hepatocellular carcinoma.
    Yarchoan, Mark
    Gane, Edward
    Marron, Thomas Urban
    Rochestie, Sarah
    Cooch, Neil
    Peters, Joann
    Csiki, Ildiko
    Perales-Puchalt, Alfredo
    Sardesai, Niranjan
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [9] Targeted agents for second-line treatment of advanced hepatocellular carcinoma
    Personeni, Nicola
    Pressiani, Tiziana
    Bozzarelli, Silvia
    Rimassa, Lorenza
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2019, 11 (10) : 788 - 803
  • [10] Targeted agents for second-line treatment of advanced hepatocellular carcinoma
    Nicola Personeni
    Tiziana Pressiani
    Silvia Bozzarelli
    Lorenza Rimassa
    World Journal of Gastrointestinal Oncology, 2019, (10) : 788 - 803
12345